HOOKIPA Pharma Inc. (HOOK Quick QuoteHOOK - Free Report) shares ended the last trading session 7.9% higher at $19.51. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 50.7% gain over the past four weeks.

Last week, the company reported record quarterly revenues of $5.3 million in the first quarter of 2021. This might have driven the rally. The company’s efforts to develop its pipeline candidates while advancing multiple clinical programs targeting various indications, is also a positive.

Price and Consensus

This company is expected to post quarterly loss of $0.54 per share in its upcoming report, which represents a year-over-year change of -92.9%. Revenues are expected to be $5.45 million, down 18.5% from the year-ago quarter.

While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

For HOOKIPA Pharma Inc., the consensus EPS estimate for the quarter has been revised 1.2% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on HOOK going forward to see if this recent jump can turn into more strength down the road.

The stock currently carries a Zacks Rank 3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>